Lucrecia Mora's profile picture

Lucrecia Mora

R2r Senior Manager at Pfizer

Lucrecia Mora is an experienced finance professional with a strong background in accounting and process management. Currently serving as an R2R Senior Manager at Pfizer since November 2016, Lucrecia oversees Record to Report activities, including General Ledger and Fixed Assets, while leading process migrations and continuous improvements. Previous roles include Accounting Supervisor at Thomson Reuters, where responsibilities involved accounts receivable, accounts payable, and bank reconciliations across multiple company codes, and Controller Regional at ADEN Business School, focusing on accounting processes and financial statement analysis. Lucrecia holds a Licentiate degree in Contabilidad y finanzas from Universidad Latinoamericana de Ciencia y Tecnología, an MBA in Finanzas from Aden Business School, and additional educational qualifications in accounting and architecture.

Links

Previous companies

Thomson Reuters logo

Org chart

Upgrade to view 0 reports


Teams

This person is not in any teams


Offices

This person is not in any offices


P

Pfizer

532 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.